121102-88-3

Basic information

• Product Name: N-Boc-2-broMo-1-propanaMine
• Synonyms: N-Boc-2-broMo-1-propanaMine;tert-butyl N-(2-bromopropyl)carbamate;tert-Butyl (2-bromopropyl)carbamate
• CAS NO: 121102-88-3
• Molecular Formula: C8H16BrNO2
• Molecular Weight: 238.12214
• Mol File: 121102-88-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: N-Boc-2-broMo-1-propanaMine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Boc-2-broMo-1-propanaMine(121102-88-3)
• EPA Substance Registry System: N-Boc-2-broMo-1-propanaMine(121102-88-3)

Safety Data

• Hazardous Substances Data: 121102-88-3(Hazardous Substances Data)

Usage

General Description

N-Boc-2-bromo-1-propanamine is a chemical compound with the formula C7H14BrNO2. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. The N-Boc group, or tert-butyloxycarbonyl, is a protecting group that is often used in organic chemistry to temporarily protect an amine group during a chemical reaction. The bromine atom in the compound provides an opportunity for further functionalization, making it a versatile building block in organic synthesis. Overall, N-Boc-2-bromo-1-propanamine is a valuable compound in the field of organic chemistry and is used as a precursor for the synthesis of a wide range of important molecules.

Upstream product

• 847259-93-2 (R)-1-((tert-butoxycarbonyl)amino)propan-2-yl methanesulfonate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 78-96-6 3-amino-2-propanol 
• 95656-86-3 tert-butyl 2-hydroxypropylcarbamate 

Downstream Products

• 1438409-77-8 (Z)-tert-butyl (2-(5-(4-ethoxybenzylidene)-2,4-dioxothiazolidin-3-yl)propyl)carbamate 

Relevant articles and documents

GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME

The present invention provides a glycosaminoglycan derivative in which a group derived from glycosaminoglycan and a group derived from a physiologically active substance having at least one of a carboxy group and a hydroxy group are coupled by covalent bond with a spacer therebetween, in which the spacer is selected in accordance with the decomposition rate of the covalent bond to the group derived from the physiologically active substance.

TRPM8 RECEPTOR ANTAGONISTS

Compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (hereinafter referred to as TRPM8), having formula (I), wherein R is selected from: - H, Br, CN, NO2, SO2NH2, SO2NHR' and SO2NR'2, where R' is selected from linear or branched C1-C4 alkyl; X is selected from: - F, C1, C1-C3 alkyl, NH2 and OH Y is selected from: - O, CH2, NH and SO2 R1 and R2, independently one from the other, are selected from - H, F and linear or branched C1-C4 alkyl; R3 and R4, independently one from the other, are selected from - H and linear or branched C1-C4 alkyl; Z is selected from: - NR6 and R6R7N+, where R6 and R7 independently one from the other, are selected from: ? H and linear or branched C1-C4 alkyl R5 is a residue selected from: - H and linear or branched C1-C4 alkyl Het is a heteroaryl group selected from - a substituted or not substituted pyrrolyl, a substituted or not substituted N- methylpyrrolyl, a substituted or not substituted thiophenyl, a substituted or not substituted furyl and a substituted or not substituted pyridinyl. Said compounds are useful in the prevention and treatment of pathologies depending on TRPM8 activity such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, inflammatory conditions and urological disorders.

Cephalosporin compound and pharmaceutical composition thereof

Cephalosporin compounds represented by the general formula (I): STR1 wherein R1 and R5 independently represent a hydrogen atom or a protective group for an amino group; R2 represents an alkyl group or a cycloalkyl group; R